HIV Vaccine: Johnson & Johnson Ends Trial After Vaccine Fails to Stop Transmission

A Phase 1 study of a new experimental HIV vaccine is showing promising results among a small group of volunteers. The findings are showing that when a two-dose regimen of the vaccine is administered eight weeks apart, an immune response is triggered...
 
HIV Vaccine: Johnson & Johnson Ends Trial After Vaccine Fails to Stop Transmission
Read on  →
Here's How Much Protein You Need to Build Muscle
 
Read on  →
71% of LGBTQ Youth Say Their Mental Health Is Declining Due to Restrictive State Laws
 
Read on  →
Inflammatory Bowel Disease: How Oxygen Chambers, Apple Watches May Improve Treatment for Crohn's, Ulcerative Colitis
 
Read on  →
Colorectal Cancer: New Blood Test May Help Determine if Chemotherapy is Needed After Surgery
 
Read on  →
More top Reads
GET STARTED  →
 
Start a custom weight loss program
fb   tt   insta
View in browser

Did a friend send you this email? Subscribe here.
To see all newsletters, click here.

Privacy   |   Unsubscribe

© 2023 Healthline Media LLC
275 7th Ave., 24th Floor
New York, NY 10001

Commentaires

Posts les plus consultés de ce blog

Chris Ramsey can take the heat, but what would relegation for QPR mean for black managers in the Premier League?

'Game of Thrones' gave fans of Missandei and Grey Worm something to love tonight